Neuraxis NRXS
NYSE NRXS
$6.15 -0.12 (-1.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neuraxis (NRXS) Change in Cash (2022 - 2025)

Neuraxis (NRXS) posted Change in Cash of $587963.0 for Q4 2025, up 136.49% sequentially from -$1.6 million in Q3 2025, and down 82.89% YoY from $3.4 million in Q4 2024.

Neuraxis (NRXS) Change in Cash (2022 - 2025) Analysis & Trends

Neuraxis has reported Change in Cash for 4 years, with the latest figure at $587963.0 in Q4 2025.

  • Quarterly Change in Cash fell 82.89% year-over-year to $587963.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (down 64.95% YoY) and the FY2025 annual result came in at $1.3 million, down 64.95% from the prior year.
  • Change in Cash rose to $587963.0 in Q4 2025 per NRXS's latest filing, from -$1.6 million in the prior quarter.
  • Over five years, Change in Cash peaked at $4.0 million in Q2 2025 and troughed at -$1.7 million in Q1 2025.
  • A 4-year average of $349387.6 and a median of $4584.5 in 2023 frame the typical range for Change in Cash.
  • The sharpest annual moves came in 2024 and 2025: Change in Cash jumped 28066.67% in 2024, then sank 53091.85% in 2025.
  • Over 4 years, Change in Cash stood at $245879.0 in 2022, then tumbled by 377.65% to -$682689.0 in 2023, then soared by 603.3% to $3.4 million in 2024, then tumbled by 82.89% to $587963.0 in 2025.
  • According to Business Quant data, Change in Cash over the past three periods registered $587963.0, -$1.6 million, and $4.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -185.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 427.25 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -2.94 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -2.83 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -37.42 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 225.59 Mn
10 Neuraxis 74.54 Mn 66.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 587,963.00
Sep 30, 2025 -1.61 Mn
Jun 30, 2025 3.98 Mn
Mar 31, 2025 -1.69 Mn
Dec 31, 2024 3.44 Mn
Sep 30, 2024 -1.50 Mn
Jun 30, 2024 1.68 Mn
Mar 31, 2024 3,192.00
Dec 31, 2023 -682,689.00
Sep 30, 2023 709,809.00
Jun 30, 2023 5,977.00
Mar 31, 2023 -208,236.00
Dec 31, 2022 245,879.00
Sep 30, 2022 -65,826.00